FDA Inspection
Cooperman Barnabas Medical Center IncCooperman Barnabas Medical Center Inc – FDA Inspection, Apr 29, 2013
Record Details
This FDA Inspection record concerns Cooperman Barnabas Medical Center Inc, with an inspection on April 29, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 29, 2013
- Product Type
- Biologics
View Company Profile
ID · abb068d9-bea2-4c9d-ae62-7ad1173a2f4b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 829353
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.60(a)Equipment observed, standardized, calibrated
- 21 CFR 606.100(b)(15)Schedules and procedures for equipment & calibration
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Cooperman Barnabas Medical Center Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 2, 2025 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 20, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 11, 2017 | Not classified | New Jersey District Office | |
| November 7, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Cooperman Barnabas Medical Center Inc
- FDA Inspection 1271693 - 2025-06-02
- FDA Inspection 1203599 - 2023-04-20
- FDA Inspection 1102095 - 2019-09-12
- FDA Inspection 1013996 - 2017-05-11
- FDA Inspection 903748 - 2014-11-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.